EUVIMEDScopri EUVIMED
Open access · CC BY-NC-ND 4.0

Complementary Analysis of Local and Systemic Effects of Dupilumab in Paediatric AD Using Tape Strips and Serum

Lisa P van der Rijst iD, Edward F Knol, Nicolaas P A Zuithoff, Constance F den Hartog Jager, Femke van Wijk, Marjolein S de Bruin-Weller iD, Marlies de Graaf iD

Clinical & Experimental Allergy · 2025

DOI: 10.1111/cea.70082 ↗

At a glance

Journal article in Clinical & Experimental Allergy, 2025. Written by Lisa P van der Rijst and 6 co-authors. Institution: Department of Dermatology and Allergology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, the Nether…. Major MEDLINE topics: Dermatitis, Atopic, Antibodies, Monoclonal, Humanized. Cited 15 times so far (Crossref); 53 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Objective

This study investigates local and systemic immune‐related proteins in tape strips and serum of paediatric atopic dermatitis (AD) patients treated with dupilumab, and explores their correlation with clinical severity.

Methods

Twenty paediatric AD patients (< 18 years) starting dupilumab treatment were included. Serum samples and tape strips from lesional and non‐lesional skin were collected at baseline, 4 and 16 weeks of treatment. Fifteen pre‐specified proteins were measured at each visit by Luminex multiplex immunoassay. Clinical severity outcome measures included the Eczema Area and Severity Index (EASI) and Numeric Rating Scale (NRS) itch. Statistical analyses included Wilcoxon signed‐rank tests and Spearman correlations.

Results

Along with clinical improvement, 16 weeks of dupilumab treatment resulted in a rapid and significant reduction in the disease‐associated mediators PARC/CCL18 and TARC/CCL17 in both tape‐stripped skin and serum. While the cytokine and chemokine profiles differed between the sampling methods, both effectively captured immunological changes associated with dupilumab treatment. Tape strips demonstrated significant reductions in innate pro‐inflammatory cytokines (IL‐8/CXCL8, IL‐18), the T cell‐recruiting chemokine CTACK/CCL27, the Type 1 immune mediator CXCL10, and tissue repair and remodelling proteins (periostin, MMP‐1) in response to treatment, but were less sensitive in detecting T cell‐derived cytokines (IL‐4, IL‐13). In both skin and serum, several proteins were significantly correlated with AD severity, as measured by EASI and NRS itch, with PARC/CCL18 emerging as the strongest correlated protein.

Conclusion

Our findings provide insight into the distinct local and systemic proteomic changes in response to dupilumab treatment in paediatric AD patients. These findings underscore the complementary roles of tape strips and serum in profiling immune and epidermal barrier proteins, highlighting the utility of minimally invasive tape stripping for monitoring proteomic responses to targeted therapies in paediatric AD.

Subjects

MeSH terms (MEDLINE)

Dermatitis, AtopicAntibodies, Monoclonal, HumanizedHumansChildMaleFemaleAdolescentCytokinesChild, PreschoolSkinTreatment OutcomeSeverity of Illness IndexBiomarkers

Author keywords

biomarkerschildrendupilumabpaediatricaproteomicsserumtape stripstopic dermatitis

Substances

dupilumabAntibodies, Monoclonal, HumanizedCytokinesBiomarkers

Authors and institutions

  • Department of Dermatology and Allergology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.

ORCID profiles: Lisa P van der Rijst, Marjolein S de Bruin-Weller, Marlies de Graaf

Cite

APA

van der Rijst, L. P., Knol, E. F., Zuithoff, N. P. A., den Hartog Jager, C. F., van Wijk, F., de Bruin-Weller, M. S., & de Graaf, M. (2025). Complementary Analysis of Local and Systemic Effects of Dupilumab in Paediatric AD Using Tape Strips and Serum. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.70082

Vancouver

van der Rijst LP, Knol EF, Zuithoff NPA, den Hartog Jager CF, van Wijk F, de Bruin-Weller MS, et al. Complementary Analysis of Local and Systemic Effects of Dupilumab in Paediatric AD Using Tape Strips and Serum. Clinical & Experimental Allergy. 2025. doi:10.1111/cea.70082

BibTeX
@article{vanderRijst2025,
  author = {van der Rijst, Lisa P and Knol, Edward F and Zuithoff, Nicolaas P A and den Hartog Jager, Constance F and van Wijk, Femke and de Bruin-Weller, Marjolein S and de Graaf, Marlies},
  title = {Complementary Analysis of Local and Systemic Effects of Dupilumab in Paediatric AD Using Tape Strips and Serum},
  journal = {Clinical & Experimental Allergy},
  year = {2025},
  doi = {10.1111/cea.70082}
}
Start for free →